In Allergy, ‘A new day has begun’
Finnish Allergy Programme 2008–2018 – time to act and change the course
House dust mite control measures for asthma
ARIA-suggested drugs for allergic rhinitis
An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma
Mechanisms of asthma in Olympic athletes – practical implications
A high-affinity monoclonal anti-IgE antibody for depletion of IgE and IgE-bearing cells
Skin reactivity and local cell recruitment in human atopic and nonatopic subjects by CCL2/MCP-1 and CCL3/MIP-1α
Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs
Distribution of Langerhans cells and mast cells within the human oral mucosa
Dysregulation of toll-like receptor-2 (TLR-2)-induced effects in monocytes from patients with atopic dermatitis
Oestrogen-dependent hereditary angio-oedema with normal C1 inhibitor
Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment
Treatment of skin swellings with C1-inhibitor concentrate in patients with hereditary angio-oedema
Characterization of Der p 21, a new important allergen derived from the gut of house dust mites*
Identification of a serine protease as a major allergen (Per a 10) of Periplaneta americana
How to assess disease activity in patients with chronic urticaria?
Do we have to recommend not using oat-containing emollients in children with atopic dermatitis?
Response to Campbell, Spackman, Sullivan letter to Allergy
Occupational allergy in a researcher due to Ole e 9, an allergenic 1,3-β-glucanase from olive pollen
Anaphylactic shock after intradermal testing with betalactam antibiotics
DRESS syndrome induced by sodium meglumine ioxitalamate
Delayed hypersensitivity to acylureidoRpenicillins
Localized cold-induced urticaria associated with specific immunotherapy for tree pollen allergy
Omalizumab in persistent severe bakers' asthma